Cargando…
Effects of levosimendan started 24 hours before cardiopulmonary bypass in patients admitted to the ICU with an ejection fraction lower than 30%
Autores principales: | Duchateau, J, Eede, H Vanden |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084053/ http://dx.doi.org/10.1186/cc7331 |
Ejemplares similares
-
Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study)
por: Caruba, Thibaut, et al.
Publicado: (2016) -
Haemodynamic effects of levosimendan in patients during weaning from cardiopulmonary bypass
por: Demeyere, R, et al.
Publicado: (2002) -
Levosimendan Reduces Lung Injury in a Canine Model of Cardiopulmonary Bypass
por: Feng, Junbo, et al.
Publicado: (2016) -
Levosimendan in patients with low ejection fraction undergoing cardiac surgery
por: Kucewicz-Czech, Ewa M., et al.
Publicado: (2018) -
Levosimendan enhances cardiac performance in patients following cardiac surgery and cardiopulmonary bypass
por: Sandell, E-P, et al.
Publicado: (2002)